Operating
Net gains (losses) on investments
Vertex Pharmaceuticals Net gains (losses) on investments decreased by 148.1% to -$2.60M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 75.9%, from -$10.80M to -$2.60M. Over 3 years (FY 2021 to FY 2024), Net gains (losses) on investments shows a downward trend with a 50.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2026
How to read this metric
An increase suggests successful investment performance, though it does not reflect operational cash generation.
Detailed definition
This reflects the non-cash impact of changes in the fair value of equity investments or securities held by the company....
Peer comparison
Varies based on the size of the company's corporate venture capital or treasury investment portfolio.
Metric ID:
cf_gain_loss_on_investmentsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.61M | $46.68M | $12.11M | -$75.60M | -$84.20M | $16.70M | -$6.00M | $6.40M | -$400.00K | -$6.20M | -$400.00K | -$27.00M | -$12.70M | -$10.80M | -$7.20M | -$15.00M | $5.40M | -$2.60M |
| QoQ Change | — | +340.0% | -74.1% | -724.4% | -11.4% | +119.8% | -135.9% | +206.7% | -106.3% | <-999% | +93.5% | <-999% | +53.0% | +15.0% | +33.3% | -108.3% | +136.0% | -148.1% |
| YoY Change | — | — | — | — | -893.7% | -64.2% | -149.6% | +108.5% | +99.5% | -137.1% | +93.3% | -521.9% | <-999% | -74.2% | <-999% | +44.4% | +142.5% | +75.9% |
Range-$84.20M – $46.68M
CAGR-28.2%
Avg YoY Growth-432.2%
Median YoY Growth-69.2%
Net gains (losses) on investments at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's net gains (losses) on investments?
- Vertex Pharmaceuticals (VRTX) reported net gains (losses) on investments of -$2.60M in Q3 2025.
- How has Vertex Pharmaceuticals's net gains (losses) on investments changed year-over-year?
- Vertex Pharmaceuticals's net gains (losses) on investments increased by 75.9% year-over-year, from -$10.80M to -$2.60M.
- What is the long-term trend for Vertex Pharmaceuticals's net gains (losses) on investments?
- Over 3 years (2021 to 2024), Vertex Pharmaceuticals's net gains (losses) on investments has grown at a 50.0% compound annual growth rate (CAGR), from $17.10M to -$57.70M.
- What does net gains (losses) on investments mean?
- Non-cash profits or losses from the company's investment portfolio.